Covered recipient · General Payments record
RUBA MEMON
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2022–2024
$1,772.04
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $785.96 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $233.68 | 13 |
| GlaxoSmithKline, LLC. | $123.50 | 1 |
| Amgen Inc. | $111.24 | 5 |
| UCB, Inc. | $82.22 | 3 |
| Aurinia Pharma U.S., Inc. | $61.72 | 3 |
| Alexion Pharmaceuticals, Inc. | $53.50 | 1 |
| Janssen Biotech, Inc. | $36.24 | 2 |
| Lilly USA, LLC | $30.56 | 1 |
| Kiniksa Pharmaceuticals International, plc | $22.38 | 1 |
| Acerta Pharma LLC | $17.48 | 1 |
| PFIZER INC. | $13.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.63 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020436 | CMS |
| ABBVIE INC. | $24.58 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020438 | CMS |
| ABBVIE INC. | $27.61 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020440 | CMS |
| ABBVIE INC. | $25.54 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020442 | CMS |
| ABBVIE INC. | $8.71 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020444 | CMS |
| ABBVIE INC. | $9.42 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020446 | CMS |
| ABBVIE INC. | $9.49 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020448 | CMS |
| ABBVIE INC. | $10.76 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020450 | CMS |
| ABBVIE INC. | $21.04 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020452 | CMS |
| ABBVIE INC. | $23.75 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020454 | CMS |
| ABBVIE INC. | $19.40 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020456 | CMS |
| ABBVIE INC. | $4.44 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020458 | CMS |
| ABBVIE INC. | $23.31 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105020460 | CMS |
| Alexion Pharmaceuticals, Inc. | $53.50 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093901688 | CMS |
| Amgen Inc. | $15.26 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115926527 | CMS |
| Amgen Inc. | $22.22 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115926531 | CMS |
| Amgen Inc. | $30.72 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117628104 | CMS |
| Amgen Inc. | $17.94 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115926538 | CMS |
| Amgen Inc. | $25.10 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117628106 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.48 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104629848 | CMS |
| Aurinia Pharma U.S., Inc. | $17.45 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150687381 | CMS |
| Aurinia Pharma U.S., Inc. | $19.70 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150687383 | CMS |
| Aurinia Pharma U.S., Inc. | $24.57 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150687385 | CMS |
| GlaxoSmithKline, LLC. | $123.50 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116145315 | CMS |
| Janssen Biotech, Inc. | $14.77 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078769967 | CMS |
| Janssen Biotech, Inc. | $21.47 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078769841 | CMS |
| Kiniksa Pharmaceuticals International, plc | $22.38 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154891297 | CMS |
| Lilly USA, LLC | $30.56 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135359240 | CMS |
| PFIZER INC. | $13.44 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130985689 | CMS |
| UCB, Inc. | $20.61 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143038521 | CMS |
| UCB, Inc. | $26.24 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143038523 | CMS |
| UCB, Inc. | $35.37 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143038525 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.